Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study-March 2024-www.financetom.com

Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study

Mar 11, 2024 1:32 PM

March 11 (Reuters) - Acadia Pharmaceuticals ( ACAD )

said on Monday its experimental drug to treat negative symptoms

of schizophrenia failed to meet the main goal in a late-stage

study.

(Reporting by Mariam Sunny in Bengaluru)

Previous page： General Dynamics Insider Sold Shares Worth $8,614,609, According to a Recent SEC Filing Next page： Bwx Technologies Insider Sold Shares Worth $624,161, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

General Dynamics Insider Sold Shares Worth $8,614,609, According to a Recent SEC Filing

Mar 6, 2025

04:58 PM EST, 03/06/2025 (MT Newswires) -- Phebe N Novakovic, Director, Chairman and CEO, on March 04, 2025, sold 32,695 shares in General Dynamics ( GD ) for $8,614,609. Following the Form 4 filing with the SEC, Novakovic has control over a total of 805,398 common shares of the company, with 769,607 shares held directly and 35,791 controlled indirectly. SEC...

Bwx Technologies Insider Sold Shares Worth $624,161, According to a Recent SEC Filing

Mar 6, 2025

04:57 PM EST, 03/06/2025 (MT Newswires) -- Robert L Duffy, Senior Vice President and Chief Administrative Officer, on March 05, 2025, sold 6,000 shares in Bwx Technologies ( BWXT ) for $624,161. Following the Form 4 filing with the SEC, Duffy has control over a total of 3,206 common shares of the company, with 3,206 shares held directly. SEC Filing:...

National CineMedia Q4 Earnings Rise, Revenue Falls; Q1 Revenue Outlook Issued

Mar 6, 2025

04:57 PM EST, 03/06/2025 (MT Newswires) -- National CineMedia ( NCMI ) reported Q4 earnings late Thursday of $0.26 per diluted share, up from $0.24 a year earlier. Three analysts polled by FactSet expected $0.18. Revenue for the quarter ended Dec. 26 was $86.3 million, down from $90.9 million a year earlier. Four analysts surveyed by FactSet expected $84.5 million....

AerSale Swings to Q4 Adjusted Profit, Revenue Up -- Share Rise Late

Mar 6, 2025

04:57 PM EST, 03/06/2025 (MT Newswires) -- AerSale ( ASLE ) late Thursday reported Q4 adjusted net income of $0.09 per diluted share, compared with a $0.02 loss a year earlier. Two analysts polled by FactSet expected $0.07. Revenue for the quarter ended Dec. 31 was $94.7 million, compared with $94.4 million a year earlier. Two analysts expected $91.6 million....